Education
About Us
Working with TipRanks
Follow Us
AdaptHealth (AHCO)
NASDAQ:AHCO
AHCO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.11 - $11.63
Previous CloseN/A
Volume245.49K
Average Volume (3M)983.29K
Market Cap
$1.20B
Enterprise Value$3.18B
Total Cash (Recent Filing)$68.63M
Total Debt (Recent Filing)$1.95B
Price to Earnings (P/E)16.6
Beta0.83
Next Earnings
Nov 11, 2025EPS Estimate
0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.22
Shares Outstanding135,297,760
10 Day Avg. Volume1,037,078
30 Day Avg. Volume983,287
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap2.64
Enterprise Value/Revenue1.05
Enterprise Value/Gross Profit6.70
Enterprise Value/Ebitda4.92
Forecast
1Y Price Target
$13.08Price Target Upside47.13% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Bulls Say, Bears Say
Bulls Say
Contract ExpansionNew contract expands AHCO's capitated business, expected to bring significant revenue and align margins with enterprise levels.
Operational ImprovementsSimplified operations and improved technology driving improvement: Management noted perhaps the greatest achievement from the first year-plus tenure of CEO Suzanne Foster is the simplified operations and investments in improved technology.
Bears Say
Earnings PerformanceEPS of $0.11 came in below both the estimate and consensus.
Financial OutlookLowering estimates for 2025-26 EBITDA forecasts, which affects the financial outlook despite maintaining the price target.
AdaptHealth News
AHCO FAQ
What was AdaptHealth’s price range in the past 12 months?
AdaptHealth lowest stock price was $7.11 and its highest was $11.63 in the past 12 months.
What is AdaptHealth’s market cap?
AdaptHealth’s market cap is $1.20B.
When is AdaptHealth’s upcoming earnings report date?
AdaptHealth’s upcoming earnings report date is Nov 11, 2025 which is in 50 days.
How were AdaptHealth’s earnings last quarter?
AdaptHealth released its earnings results on Aug 05, 2025. The company reported $0.218 earnings per share for the quarter, beating the consensus estimate of $0.158 by $0.06.
Is AdaptHealth overvalued?
According to Wall Street analysts AdaptHealth’s price is currently Undervalued.
Does AdaptHealth pay dividends?
AdaptHealth does not currently pay dividends.
What is AdaptHealth’s EPS estimate?
AdaptHealth’s EPS estimate is 0.24.
How many shares outstanding does AdaptHealth have?
AdaptHealth has 135,297,760 shares outstanding.
What happened to AdaptHealth’s price movement after its last earnings report?
AdaptHealth reported an EPS of $0.218 in its last earnings report, beating expectations of $0.158. Following the earnings report the stock price went up 10.977%.
Which hedge fund is a major shareholder of AdaptHealth?
Currently, no hedge funds are holding shares in AHCO
AdaptHealth Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.08 (47.13% Upside)
$13.08 (47.13% Upside)
Blogger Sentiment
Bullish
AHCO Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 238.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $79.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 6.3%
Last 30 Days ▼ 6.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.32%
12-Months-Change
Fundamentals
Return on Equity
4.76%
Trailing 12-Months
Asset Growth
-3.55%
Trailing 12-Months
Company Description
AdaptHealth
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
AHCO Company Deck
AHCO Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a balanced view with significant achievements such as a major new contract and advancements in technology, countered by challenges like revenue decline and potential pressures from regulatory changes. The sentiment is mixed with strong strategic positioning for future growth but current financial pressures.View all AHCO earnings summariesAHCO Stock 12 Month Forecast
Average Price Target
$13.08
▲(47.13% Upside)
Technical Analysis
Ufp Technologies
―
LivaNova
―
Senseonics Holdings
―
Establishment Labs Holdings
―
Bioventus
―
Ownership Overview
3.30% Insiders
22.68% Mutual Funds
6.14% Other Institutional Investors
44.47% Public Companies and
Individual Investors